About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Genetico
Gemabank
Nextgen
Biotechnology Developments
Betuvax
Histograft
Genotarget
Reprobank
Vitacel
14.01.2026
Press releases
Cifra Broker Publishes Analytical Review of Artgen Biotech for 9M 2025
13.01.2026
Press releases
Acceleration of Clinical Trials: New Treatment for Interstitial Cystitis to Be Tested Two Years Faster
25.12.2025
Press releases
Innovative Eye Gel Developed Based on RBT’s «Betusphere»
23.12.2025
Press releases
Gemabank to Pay Out Dividends for 9M 2025
16.12.2025
Press releases
Artgen Biotech Places Bonds with Fivefold Oversubscription
28.11.2025
News
Novel Cat Allergy Treatment «Betuvax» Generates Excitement at the Young Scientists Congress in Sirius
21.11.2025
Press releases
Adaptation to Market Changes: RBT Formulates a Medium-Term Development Strategy
1
2
3
4
5
…
26
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
